Alzheimer Dementia Clinical Trial
Official title:
Reappraising Intergeneration Relationships in Dementia Caregiving Through Perspective Taking
It is hypothesized that reappraising intergeneration relationships through perspective-taking
will enhance the well-being of adult-child caregivers. Incorporating both psychological and
social perspectives, the study makes a unique contribution to address research gaps by
evaluating an integrated model of intervention for dementia caregivers. The conceptual model
involves the following components: 1) relational insights; 2) self-reflection to integrate
the challenges and benefits in caregiving; 3) interpersonal empathy
To test the incremental value of perspective-taking reappraisals, the study involves a
two-arm randomized controlled trial of 12 weeks of intervention with two conditions: 1)
Reappraisal through Perspective Taking and 2) Basic Skill Building. Telephone-administered
sessions are integrated with group sessions and home visits to maximize sustainability and
accessibility of the intervention. One hundred fifty-four participants will be recruited and
randomized. Primary outcomes are reduced depressive symptoms and enhanced psychological
well-being for the caregivers. Secondary outcomes include enhanced social support for
caregivers and reduced behavioral problems in the care-recipients.
Status | Recruiting |
Enrollment | 154 |
Est. completion date | July 8, 2021 |
Est. primary completion date | July 8, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 20 Years to 60 Years |
Eligibility |
Inclusion criteria are as follows - Primary caregivers aged 20 or older and who have been caring for persons (aged 60 or above) with a physician diagnosis of Alzheimer's disease in the mild to moderate range as determined by the Clinical Dementia Rating Scale. - Primary caregivers who have been providing unpaid care for more than 12 hours a week for at least the past three months. - The care should involve day-to-day decision-making as well as any of the following: feeding, dressing, bathing, toileting, housework, preparing meals, medication and handling finances. - They can be daughter/son or daughter-/son-in-law of the care recipient. Exclusion criteria are as follows: - signs of severe intellectual deficits - demonstrated suicidal ideation - exhibited evidence of psychotic disorders - hearing/ visual impairment - inability to read or speak Chinese/Cantonese fluently and severe. |
Country | Name | City | State |
---|---|---|---|
Hong Kong | Applied Social Sciences, Hong Kong Polytechnic University | Hong Kong | |
Hong Kong | Institute of Active Ageing | Kowloon |
Lead Sponsor | Collaborator |
---|---|
The Hong Kong Polytechnic University |
Hong Kong,
Au A, Gallagher-Thompson D, Wong MK, Leung J, Chan WC, Chan CC, Lu HJ, Lai MK, Chan K. Behavioral activation for dementia caregivers: scheduling pleasant events and enhancing communications. Clin Interv Aging. 2015 Mar 26;10:611-9. doi: 10.2147/CIA.S72348. eCollection 2015. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Center for Epidemiological Studies-Depression Search Results Center for Epidemiological Studies Depression | 20-item measure that asks caregivers to rate how often over the past week they The scale rates experienced symptoms associated with depression.. Response options range from 0 to 3 for each item (0 = Rarely or None of the Time, 1 = Some or Little of the Time, 2 = Moderately or Much of the time, 3 = Most or Almost All the Time). Scores range from 0 to 60, with high scores indicating greater level of having depressive symptoms. | Week 1, 6, 12, 24 | |
Primary | Change in Ryff's Psychological Well-being | The 18-version of the scale taps the six areas of psychological well-being: autonomy, environmental mastery, personal growth, positive relations with others, purpose in life, and self-acceptance. Respondents rate statements on a scale of 1 to 6, with 1 indicating strong disagreement and 6 indicating strong agreement. The range of scores is from 0 to 108. Higher scores suggest higher levels of well-being. The subscale score of each of the six areas can be calculating by summation of the three items associated with each of the area. | Weeks 1,6, 12, 24 | |
Secondary | Change in Revised Memory and Problem Checklist | The checklist is a 24-item caregiver-report measure provides a total score plus scores for three subscale memory-related problems, affective distress and disruptive behaviors. Scores are computed for the presence or absence of each problem first, and then for caregiver "reaction" or the extent to which caregivers were "bothered" or "distressed" by each behavior. The caregivers' reaction to each behavior, or the extent of distress experienced, were scored as follows: Reactions are assessed by asking how "upsetting" the behavior was on a Likert scale of 0 to 4 (0 = Not at all, 1= a little, 2 = moderately, 3 = very much, and 4 =extremely). Frequency of behaviors are assessed based on a Likert-scale of 0 to 4 (0 = never occurs, 1 = occurs infrequently and not in the last week, 2 = occurred 1-2 times in the last week, 3 = occurred 3-6 times in the last week, and 4 = occurs daily or more often). The range of score is from 0 to 96, higher scores suggesting greater disruption. | Weeks 1, 6, 12 ,24 | |
Secondary | Change in MacArther Social Support Scales | The measure the levels of emotional and instrumental social support experienced by the caregivers. The scale consists of 12 items assesses the frequency of receipt of 3 categories of social support: emotional support, instrumental support and negative interaction involving conflict or excessive demands. The participants scored each item on a 5-point Likert Scale ranging from 0 (never) to 4 (frequently). The range of scores is from 0 to 48, with higher score indicating better social support. | Weeks 1,6, 12, 24 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT03255720 -
Application of Diffusion Tensor Imaging in Alzheimer's Disease :Quantification of White Matter Micro-structural Changes
|
N/A | |
Recruiting |
NCT03507192 -
Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia.
|
N/A | |
Withdrawn |
NCT05497817 -
A Study to Evaluate Caregiver Connections Via Technology for Patients With Alzheimer's and Other Types of Dementia
|
N/A | |
Completed |
NCT02317523 -
Alzheimer's Caregiver Coping: Mental and Physical Health
|
N/A | |
Completed |
NCT03538522 -
A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831
|
Phase 2 | |
Terminated |
NCT03132272 -
Immunoadsorption for Treatment of Alzheimer's Disease
|
N/A | |
Recruiting |
NCT03275363 -
The University of Hong Kong Neurocognitive Disorder Cohort
|
N/A | |
Enrolling by invitation |
NCT03724136 -
Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study
|
N/A | |
Completed |
NCT02267486 -
Exploratory Study for the Validity of QuQu Scale
|
N/A | |
Active, not recruiting |
NCT03748303 -
Allopregnanolone Regenerative Therapeutic for Early Alzheimer's Disease: Intramuscular Study
|
Phase 1 | |
Completed |
NCT03611439 -
Effects of an 8 Component Botanical Supplement on Mild and Moderate Alzheimer's Patients
|
N/A | |
Completed |
NCT04058886 -
Telephone-delivered Mindfulness Intervention for African American Dementia Caregivers
|
N/A | |
Not yet recruiting |
NCT05113732 -
Association of Cognition With Functional Mobility in People With Alzheimer's Disease
|
||
Completed |
NCT03811847 -
A Pilot of Methylphenidate in Mild Cognitive Impairment and Dementia Participants.
|
Phase 4 | |
Terminated |
NCT03044249 -
A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression
|
Phase 2 | |
Active, not recruiting |
NCT03661034 -
Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)
|
N/A | |
Completed |
NCT03718494 -
Continuation of The Kronos Early Estrogen Prevention Study (KEEPS)
|
||
Completed |
NCT03602391 -
The Senior Companion Program Plus
|
N/A | |
Completed |
NCT03548584 -
A Trial to Evaluate the Safety, Efficacy, and Tolerability of Brexpiprazole in Treating Agitation Associated With Dementia of the Alzheimer's Type
|
Phase 3 | |
Recruiting |
NCT02951559 -
SOLFAMU Study of Nasal Brushing Collected OLFActory MUcosa Samples in the Diagnosis of Human Encephalopathies
|
Phase 4 |